Heparin

According to an April 21 AP article, the FDA issued a warning Monday to Changzhou SPL, the company that manufactures the blood-thinning drug Heparin. The FDA informed the pharmaceutical manufacturing company that it is not doing an adequate job of removing impurities from the raw materials it uses. However, the company maintains that it does ...